As the U.S. and Israel escalate military strikes on Iran, the response from European governments has varied from limited ...
Prime Medicine (PRME) stock slides as the company releases Q4 2025 results and upates on its clinical programs. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results